Wells Fargo’s Allena Pharmaceuticals ALNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,053
| Closed | – | – | 7875 |
|
|
2022
Q2 | $0 | Buy |
3,053
+85
| +3% | +$13 | ﹤0.01% | 7945 |
|
|
2022
Q1 | $1K | Buy |
2,968
+16
| +0.5% | +$7 | ﹤0.01% | 6930 |
|
|
2021
Q4 | $1K | Buy |
2,952
+1,529
| +107% | +$1.2K | ﹤0.01% | 7135 |
|
|
2021
Q3 | $1K | Buy |
1,423
+167
| +13% | +$164 | ﹤0.01% | 6879 |
|
|
2021
Q2 | $1K | Buy |
1,256
+31
| +3% | +$38 | ﹤0.01% | 6808 |
|
|
2021
Q1 | $1K | Sell |
1,225
-1
| -0.1% | -$2 | ﹤0.01% | 6816 |
|
|
2020
Q4 | $1K | Buy |
1,226
+86
| +8% | +$120 | ﹤0.01% | 6411 |
|
|
2020
Q3 | $1K | Buy |
1,140
+55
| +5% | +$77 | ﹤0.01% | 6260 |
|
|
2020
Q2 | $2K | Sell |
1,085
-2,100
| -66% | -$3.53K | ﹤0.01% | 6130 |
|
|
2020
Q1 | $3K | Buy |
3,185
+85
| +3% | +$170 | ﹤0.01% | 5966 |
|
|
2019
Q4 | $8K | Sell |
3,100
-9,089
| -75% | -$29.8K | ﹤0.01% | 5961 |
|
|
2019
Q3 | $48K | Buy |
12,189
+438
| +4% | +$1.88K | ﹤0.01% | 5571 |
|
|
2019
Q2 | $48K | Sell |
11,751
-9,560
| -45% | -$52.2K | ﹤0.01% | 5569 |
|
|
2019
Q1 | $150K | Buy |
21,311
+7,283
| +52% | +$52.8K | ﹤0.01% | 4964 |
|
|
2018
Q4 | $76K | Buy |
14,028
+7,359
| +110% | +$63.4K | ﹤0.01% | 5405 |
|
|
2018
Q3 | $72K | Buy |
6,669
+3,250
| +95% | +$35.7K | ﹤0.01% | 5477 |
|
|
2018
Q2 | $44K | Sell |
3,419
-5,917
| -63% | -$85.3K | ﹤0.01% | 5631 |
|
|
2018
Q1 | $103K | Buy |
9,336
+6,641
| +246% | +$55.5K | ﹤0.01% | 5288 |
|
|
2017
Q4 | $27K | Buy |
+2,695
| New | +$33.2K | ﹤0.01% | 5717 |
|
Other funds holding ALNA
Wells Fargo's ALNA Position: Q3 2022 in Review
Wells Fargo sold out of Allena Pharmaceuticals (ALNA) in Q3 2022, closing a stake of 3,053 shares.
Wells Fargo first reported a position in ALNA in Q4 2017 and held it in 19 quarters. The position peaked at $150K in Q1 2019. 2 funds tracked by Wall St. Rank hold ALNA as of Q3 2022.
- Wells Fargo reported no remaining Allena Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
- Wells Fargo sold 3,053 Allena Pharmaceuticals shares in Q3 2022.
- Wells Fargo first reported a position in Allena Pharmaceuticals in Q4 2017 and held it in 19 quarters.
- Wells Fargo's Allena Pharmaceuticals position peaked at $150K in Q1 2019.
- 2 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2022.
Based on Wells Fargo's 13F filing for Q3 2022, filed 14 Nov 2022.